Back
Bionano Genomics 10K Form
Sell
11
BNGO
Bionano Genomics
Last Price:
0.22
Seasonality Move:
400.39%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive BNGO News And Ratings
See the #1 stock for the next 7 days that we like better than BNGO
BNGO Financial Statistics
Sales & Book Value
| Annual Sales: | $36.12M |
|---|---|
| Cash Flow: | $-13.31M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.55 |
| Price / Book: | 0.47 |
Profitability
| EPS (TTM): | -4.48000 |
|---|---|
| Net Income (TTM): | $-135.78M |
| Gross Margin: | $9.57M |
| Return on Equity: | -158.95% |
| Return on Assets: | -88.05% |
Bionano Genomics Earnings Forecast
Key Bionano Genomics Financial Ratios
- The Gross Profit Margin over the past 8 years for BNGO is 26.49%.
- The Selling, General & Administrative Expenses for BNGO have been equal to 258.89% of Gross Profit Margin.
- The Research & Development expenses have been 149.61% of Revenue.
- The Interest Expense is -2.20% of Operating Income.
- The Net Earning history of BNGO is -643.74% of Total Revenues.
- Per Share Earnings over the last 8 years have been positive in 4 years.
Bionano Genomics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Life Sciences Tools & Services |
| Sector: | Health Care |
| Current Symbol: | BNGO |
| CUSIP: | 09075F |
| Website: | bionano.com |
Debt
| Debt-to-Equity Ratio: | 0.31 |
|---|---|
| Current Ratio: | 1.43 |
| Quick Ratio: | 0.86 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
BNGO Technical Analysis vs Fundamental Analysis
Sell
11
Bionano Genomics (BNGO)
is a Sell
Is Bionano Genomics a Buy or a Sell?
-
Bionano Genomics stock is rated a Sell
The current Bionano Genomics [BNGO] share price is $0.22. The Score for BNGO is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.